HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Regression of skin lesions of Kyrle's disease with metronidazole in a diabetic patient.

Abstract
We describe here in a case of a 41-year-old man, with diabetes mellitus, who presented manifestations of Kyrle's disease. Administration of metronidazole, 500 mg twice daily for 1 month, resulted in complete regression of skin lesions with no recurrence during 12 months of follow-up. This successful antibiotic treatment is to support the role of infectious agents (anaerobic bacteria) in the pathogenesis of Kyrle's disease.
AuthorsM Khalifa, I Slim, N Kaabia, F Bahri, A Trabelsi, A Omezzine Letaief
JournalThe Journal of infection (J Infect) Vol. 55 Issue 6 Pg. e139-40 (Dec 2007) ISSN: 1532-2742 [Electronic] England
PMID17905437 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Anti-Infective Agents
  • Metronidazole
Topics
  • Adult
  • Anti-Infective Agents (therapeutic use)
  • Diabetes Mellitus (pathology)
  • Humans
  • Keratosis (drug therapy, etiology)
  • Male
  • Metronidazole (administration & dosage, therapeutic use)
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: